Cargando…

Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study

Detalles Bibliográficos
Autores principales: Tanihara, Hidenobu, Kakuda, Takahiko, Sano, Tetsuro, Kanno, Takashi, Gunji, Ryoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487738/
https://www.ncbi.nlm.nih.gov/pubmed/32887561
http://dx.doi.org/10.1186/s12886-020-01595-7
_version_ 1783581549643431936
author Tanihara, Hidenobu
Kakuda, Takahiko
Sano, Tetsuro
Kanno, Takashi
Gunji, Ryoji
author_facet Tanihara, Hidenobu
Kakuda, Takahiko
Sano, Tetsuro
Kanno, Takashi
Gunji, Ryoji
author_sort Tanihara, Hidenobu
collection PubMed
description
format Online
Article
Text
id pubmed-7487738
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74877382020-09-16 Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study Tanihara, Hidenobu Kakuda, Takahiko Sano, Tetsuro Kanno, Takashi Gunji, Ryoji BMC Ophthalmol Correction BioMed Central 2020-09-04 /pmc/articles/PMC7487738/ /pubmed/32887561 http://dx.doi.org/10.1186/s12886-020-01595-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Tanihara, Hidenobu
Kakuda, Takahiko
Sano, Tetsuro
Kanno, Takashi
Gunji, Ryoji
Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
title Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
title_full Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
title_fullStr Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
title_full_unstemmed Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
title_short Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
title_sort correction to: safety and efficacy of ripasudil in japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of rock-j, a post-marketing surveillance study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487738/
https://www.ncbi.nlm.nih.gov/pubmed/32887561
http://dx.doi.org/10.1186/s12886-020-01595-7
work_keys_str_mv AT taniharahidenobu correctiontosafetyandefficacyofripasudilinjapanesepatientswithglaucomaorocularhypertension12monthinterimanalysisofrockjapostmarketingsurveillancestudy
AT kakudatakahiko correctiontosafetyandefficacyofripasudilinjapanesepatientswithglaucomaorocularhypertension12monthinterimanalysisofrockjapostmarketingsurveillancestudy
AT sanotetsuro correctiontosafetyandefficacyofripasudilinjapanesepatientswithglaucomaorocularhypertension12monthinterimanalysisofrockjapostmarketingsurveillancestudy
AT kannotakashi correctiontosafetyandefficacyofripasudilinjapanesepatientswithglaucomaorocularhypertension12monthinterimanalysisofrockjapostmarketingsurveillancestudy
AT gunjiryoji correctiontosafetyandefficacyofripasudilinjapanesepatientswithglaucomaorocularhypertension12monthinterimanalysisofrockjapostmarketingsurveillancestudy